These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15693091)

  • 1. Effect of Helicobacter pylori and eradication therapy on gastrointestinal permeability. Implications for patients with seronegative spondyloarthritis.
    Di Leo V; D'Inca R; Bettini MB; Podswiadek M; Punzi L; Mastropaolo G; Sturniolo GC
    J Rheumatol; 2005 Feb; 32(2):295-300. PubMed ID: 15693091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
    De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
    J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study.
    Schaeverbeke T; Broutet N; Zerbib F; Combe B; Bertin P; Lamouliatte H; Perié F; Joubert-Collin M; Mégraud F
    Am J Gastroenterol; 2005 Dec; 100(12):2637-43. PubMed ID: 16393213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?
    Kiltz U; Zochling J; Schmidt WE; Braun J
    Rheumatology (Oxford); 2008 Sep; 47(9):1342-7. PubMed ID: 18477642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test.
    Magen E; Mishal J; Schlesinger M; Scharf S
    Helicobacter; 2007 Oct; 12(5):567-71. PubMed ID: 17760727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
    Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
    Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.
    Gisbert JP; Calvet X; Feu F; Bory F; Cosme A; Almela P; Santolaria S; Aznárez R; Castro M; Fernández N; García-Grávalos R; Cañete N; Benages A; Montoro M; Borda F; Pérez-Aisa A; Piqué JM
    Helicobacter; 2007 Aug; 12(4):279-86. PubMed ID: 17669099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens].
    Cheng H; Hu FL; Li J
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2679-82. PubMed ID: 17199976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of the Helicobacter pylori stool antigen test and urea breath test is useful for clinical evaluation of eradication therapy: a multicenter study.
    Ito M; Tanaka S; Kim S; Tahara K; Kawamura Y; Sumii M; Takehara Y; Hayashi K; Okamoto E; Kunihiro M; Kunita T; Imagawa S; Takata S; Ueda H; Egi Y; Hiyama T; Ueno Y; Kitadai Y; Yoshihara M; Chayama K
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1241-5. PubMed ID: 16048573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
    Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial.
    Suzuki T; Matsushima M; Masui A; Watanabe K; Takagi A; Ogawa Y; Shirai T; Mine T
    Am J Gastroenterol; 2005 Jun; 100(6):1265-70. PubMed ID: 15929755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study.
    Di Mario F; Moussa AM; Dal Bò N; Caruana P; Pilotto A; Cavallaro LG; Cavestro GM; Iori V; Merli R; Franzé A; Rugge M
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1661-6. PubMed ID: 16246182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Ez-HBT Helicobacter blood test to establish Helicobacter pylori eradication.
    Ahmed F; Murthy UK; Chey WD; Toskes PP; Wagner DA
    Aliment Pharmacol Ther; 2005 Nov; 22(9):875-80. PubMed ID: 16225498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of a serologic test with a current infection marker of Helicobacter pylori before and after eradication therapy in Chinese.
    Wang XY; Yang Y; Shi RH; Ho B; Wang HD; Zhang GX
    Helicobacter; 2008 Feb; 13(1):49-55. PubMed ID: 18205666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.